Videos Gene editing will dramatically transform medicine and life, so should you just buy-and-hold the stocks? Articles You May Like Op-ed: Here’s why a sale of Bausch + Lomb could lead to a windfall for Bausch Health investors This 38-year-old is financially independent with passive income. Here’s how he built a 7-figure real estate portfolio Senators preview coming tax debate, SALT, housing, capital gains on table Point72’s Steve Cohen is stepping back from trading his own book Top Wall Street analysts pick these dividend stocks for attractive returns